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Abstract
The peptidoglycan (PG) cell wall is an essential component of the cell envelope of most
bacteria. Biogenesis of PG involves a lipid-linked disaccharide-pentapeptide intermediate
called lipid II, which must be translocated across the cytoplasmic membrane after it is syn-
thesized in the inner leaflet of this bilayer. Accordingly, it has been demonstrated that MurJ,
the proposed lipid II flippase in Escherichia coli, is required for PG biogenesis, and thereby
viability. In contrast, MurJ is not essential in Bacillus subtilis because this bacterium pro-
duces AmJ, an unrelated protein that is functionally redundant with MurJ. In this study, we
investigated why MurJ is not essential in the prominent gastric pathogen, Helicobacter
pylori. We found that in this bacterium, Wzk, the ABC (ATP-binding cassette) transporter
that flips the lipid-linked O- or Lewis- antigen precursors across the inner membrane, is
redundant with MurJ for cell viability. Heterologous expression ofwzk in E. coli also sup-
presses the lethality caused by the loss ofmurJ. Furthermore, we show that this cross-spe-
cies complementation is abolished whenWzk is inactivated by mutations that target a
domain predicted to be required for ATPase activity. Our results suggest that Wzk can flip
lipid II, implying that Wzk is the flippase with the most relaxed specificity for lipid-linked sac-
charides ever identified.
Introduction
The cell envelope of most bacteria contains a cell wall composed of peptidoglycan (PG) [1].
Bacteria build the PG matrix around their cytoplasmic membrane by polymerizing a disaccha-
ride-pentapeptide into glycan chains that are crosslinked by peptide bonds [2, 3]. The resulting
PG polymer protects cells from osmotic lysis in hypotonic environments, confers cell shape,
and serves as an anchor to which envelope structures can be attached. Given these important
roles in bacterial physiology, it is not surprising that inhibiting PG biogenesis is lethal under
most conditions and that many antibiotics function by inhibiting this process [4].
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The PG biogenesis pathway is highly conserved among PG-producers, although there can
be some differences in the composition of the disaccharide-pentapeptide and in the complexity,
thickness and modifications of the final PG structure [3, 5, 6]. In Gram-negative bacteria,
Escherichia coli has been the model organism for most studies on PG biogenesis [7]. Early stud-
ies determined that in E. coli, the disaccharide-pentapeptide is composed of GlcNAc-MurNAc-
L-Ala-γ-D-Glu-meso-A2pm-D-Ala-D-Ala, which is synthesized at the inner leaflet of the cyto-
plasmic (or inner) membrane (Fig 1) using cytoplasmic nucleotide-linked sugars and the lipid
carrier undecaprenyl pyrophosphate (Und-PP) [8–12]. The resulting lipid-linked PG precur-
sor, known as lipid II, must then be translocated across the membrane so that it can be used by
the transglycosylases that build the PG glycan chains in the periplasm (Fig 1) [7, 13]. Clearly,
translocation (or flipping) of lipid II across the cytoplasmic membrane is an obligatory step in
PG biogenesis; however, lipid II flipping remains poorly understood and the identification of
lipid II flippases has been controversial [14, 15]. In fact, three proteins, MurJ, AmJ, and FtsW,
have been proposed to be lipid II flippases but only MurJ and AmJ have been shown to be
required for the translocation of lipid II in cells [16–20].
MurJ (formerly MviN) was initially proposed to be the lipid II flippase in E. colimainly
because 1) it is essential for PG biogenesis and, therefore, viability, 2) its depletion leads to the
accumulation of lipid-linked and nucleotide PG precursors, and 3) it belongs to the MOP (mul-
tidrug/oligo-saccharidyl-lipid/polysaccharide) exporter superfamily of proteins, which includes
flippases of substrates similar to lipid II [16, 17, 21]. Additional structure-function analyses
demonstrated that the first 12 of the 14 transmembrane domains of MurJ adopt a structure
similar to that of multidrug transporters of the MOP exporter superfamily [22]. Specifically,
these 12 transmembrane segments organize into two six-helix bundles that fold into a V-
shaped structure with a solvent-exposed central cavity that contains several charged residues
that are essential for function [22, 23]. More recently, a chemical genetics approach to inacti-
vate MurJ and an in vivo lipid II flippase assay were developed and combined to demonstrate
that rapid inactivation of MurJ with a small molecule results in the accumulation of lipid II in
the inner leaflet of the cytoplasmic membrane of E. coli cells [20]. Thus, MurJ is required for
lipid II translocation across the cytoplasmic membrane of E. coli and has structural features
that are essential for its function and similar to those found in other transporters. Conse-
quently, the simplest explanation of this collection of data is that MurJ is the lipid II flippase in
E. coli [20].
PutativemurJ orthologs are present in PG producers and their essentiality has been demon-
strated in several species of both Gram-negative and Gram-positive bacteria [16, 17, 24–27].
Cross-complementation between distant homologs has also been reported. For example, heter-
ologous expression of themurJ ortholog from Streptococcus pyogenes in E. coli can complement
the loss of the native E.coli murJ (murJEC) even though MurJEC and MurJSP only share 22% of
amino acid sequence identity [23, 28]. Unexpectedly, in B. subtilis, the MurJ homolog (MurJBS,
formerly YtgP) is not essential, although it can functionally substitute in E. coli for MurJEC [29,
30]. This paradox was recently explained by demonstrating that B. subtilis possesses AmJ (for-
merly YdaH), a protein that is functionally redundant with MurJBS that can also substitute for
MurJEC in E. coli [18]. Accordingly, B. subtilis single mutants lacking either MurJBS or AmJ are
viable but a mutant lacking both proteins is not [18].
Transcription of amJ is under the control of σM, a sigma factor that is induced by cell wall
stress [18]. This type of regulation favors the idea that AmJ plays a direct role in PG biogenesis
under certain conditions. However, AmJ is predicted to have six transmembrane domains and
is neither widely conserved among bacteria nor related to MurJ [18]. This raises the question of
whether AmJ is solely a dedicated lipid II flippase or a promiscuous flippase that can translo-
cate various substrates including lipid II. This question is especially relevant because, as
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described below, bacteria synthesize a variety of envelope glycoconjugates whose biosynthetic
pathways include lipid II-like intermediates, some of which are translocated by flippases with
relaxed substrate specificity [31, 32].
Bacteria synthesize many oligo- or poly- saccharides linked to the lipid carrier Und-PP in
the cytoplasmic leaflet of their cytoplasmic membrane. Like lipid II, these lipid-linked precur-
sors must be flipped across the membrane to be used in the synthesis of envelope components
such as capsules, O antigens, wall teichoic acids, and glycoconjugates used in N-glycosylation
[33, 34]. Several types of membrane transporters implicated in flipping Und-PP-linked inter-
mediates have been described: 1) those belonging to the MOP exporter superfamily such as
Wzx proteins and MurJ [21, 33, 35]; 2) ATP-binding cassette (ABC) transporters [36]; 3)
synthase-dependent transporters [33]; and 4) unrelated transporters such as AmJ and one
composed of ArnE and ArnF [18, 37]. How these transporters recognize their respective Und-
PP-linked intermediate is poorly understood, although it is clear that some are capable of flip-
ping more than their cognate substrate [31, 32].
An example of a translocase with relaxed substrate specificity is Wzk, the ABC transporter
involved in lipopolysaccharide (LPS) synthesis in the Gram-negative bacteriumHelicobacter
pylori [32]. In this bacterium, Wzk is required for the synthesis of O antigens, which are made
of repeats of Lewis X or Lewis Y antigens. These structures mimic human glycans playing a
role in interactions with the host and are regulated by phase variation [38, 39]. Wzk is homolo-
gous to PglK, the ABC transporter that translocates the Und-PP-heptasaccharide that Cam-
pylobacter jejuni uses in N-glycosylation of proteins [31, 40]. It was shown that when produced
Fig 1. MurJ andWzk translocate Und-PP linked saccharides across the cytoplasmic membrane.Nucleotide-linked sugars (not
shown) are used to build the PG precursor lipid II and the O-antigen precursor Und-PP-O-antigen on the membrane-bound lipid carrier
Und-P. The first Und-P glycosyltransferase in each respective pathway are MraY (not shown) andWecA. After each Und-PP-linked
intermediate is synthesized in the inner leaflet of the cytoplasmic membrane, flippases MurJ andWzk translocate them across the
bilayer. At the periplasmic leaflet of the cytoplasmic membrane, the disaccharide-pentapeptide component of lipid II is used to build
glycan chains that are crosslinked into the preexisting PGmatrix, while the O polysaccharide portion of Und-PP-O-antigen is transferred
onto LPSmolecules by the WaaL ligase (not shown). After these steps, the lipid carrier is recycled (green dotted arrows). The O
polysaccharide is composed of N-acetyl glucosamine (GlcNAc, grey hexagon labeled G), galactose (green squares), and fucose
(orange triangles); the disaccharide in lipid II is composed of N-acetyl muramic acid (MurNAc, black hexagon labeled M) and GlcNAc
(grey hexagon labeled G), while the pentapeptide is composed of L-Ala (light blue circle), D-Glu (green circle),meso-2,6-diaminopimelic
acid (meso-A2pm, red circle) and two D-Ala (dark blue circle) residues.
doi:10.1371/journal.pone.0161587.g001
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in an E. coli strain that expresses the N-glycosylation system from C. jejuni,H. pyloriWzk
(WzkHP) could substitute for PglK [32]. Moreover, WzkHP was also able to flip the Und-
PP-O16 antigen precursor that E. coli uses to modify its LPS. Thus, Wzk can flip a variety of
Und-PP-oligo- and poly- saccharides [32].
Interestingly, in H. pyloriMurJ (MurJHP) is not essential although transposon disruption of
murJHP confers defects in cell shape characteristic of a faulty PG biogenesis pathway [41]. In
this study, we demonstrate that MurJHP becomes essential in the absence of Wzk, suggesting
that both MurJHP and Wzk translocate lipid II in H. pylori. Furthermore, we show that Wzk
can substitute for MurJEC in E. coli, and that this complementation requires an active ATPase
domain. Collectively, these results suggest that H. pyloriWzk has the most relaxed specificity
for lipid-linked saccharides ever characterized as it promotes the delivery of complex O-anti-
gen, protein glycosylation and peptidoglycan precursors across the inner membrane.
Materials and Methods
Growth conditions and reagents
H. pylori were grown in Brucella broth with 10% fetal bovine serum (BB10) or on Columbia
agar plates containing 10% horse blood (HB) in a microaerophilic environment (10% O2, 10%
CO2, 80% N2) as described [41]. For resistance marker selection HB agar plates were supple-
mented with 15 μg/mL chloramphenicol or 25 μg/mL kanamycin. For E. coli cultures, lysogeny
broth (LB) and glucose M63 minimal broth were prepared as described previously [42]. Solid
media were prepared by adding 15 g/l of agar. Except for recombineering [43], all liquid cul-
tures were grown under aeration at 37°C and their growth was monitored by optical density at
600 nm (OD600). When appropriate, kanamycin (25 μg/ml), ampicillin (125 μg/ml), 5-bromo-
4-chloro-indolyl-β-D-galactopyranoside (X-gal, 20 μg/ml), and isopropyl β-D-1-thiogalacto-
pyranoside (IPTG) were added.
H. pylori strain construction
Strains are listed in S1 Table. Targeted disruption of wzx was accomplished using PCR SOEing
[44] with primers 1153_for_out, 1153#2a, 1153Kan#3, 1153Kan#4 (S2 Table) leading to
replacement of 399 bp of the coding sequence with aphA3 conferring resistance to kanamycin
[45]. The resulting PCR product was used directly for natural transformation of LSH100.
Genomic DNA was prepared from kanamycin resistant clones by Wizard genomic DNA puri-
fication kit (Promega) and the correction integration event was confirmed by PCR analysis
with primers 1153_for_out and 1153#2a [46]. A mutation in wecA was recovered by sequenc-
ing random clones from a transposon mutant library created in strain G27 [47]. Genomic
DNA prepared from a clone with a transposon insertion at genomic position 1644261 (position
651 of the 1002 bp gene) was used for natural transformation of LSH100 followed by selection
on chloramphenicol containing plates. Primes1516_rev_in and 1519_rev_in (S2 Table) were
used to confirm the integration event by PCR on genomic DNA prepared from selected clones.
Generation of Wzk variants
Site-directed mutagenesis was employed to generate inactive variants of Helicobacter pylori J99
Wzk. Primer pairs WzkS405A fw and rv, WzkD524A fw and rv, WzkE525A fw and rv (S2
Table), were used in separate PCR reactions to amplify pIH23 (pEXT20 encoding wzk) [32].
The methylated template DNA was selectively digested with DpnI (New England Biolabs),
while the amplified plasmid variants were used to transform E. coli DH5α (S1 Table). The
resulting clones were used to purify the plasmids expressing wzk variants. All point mutations
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were confirmed by sequencing. To test the expression of Wzk and its variants in E. coli DH5α,
different strains were grown to mid-logarithmic phase. Expression of wzk alleles was induced
with 0.5 mM IPTG for 4 hrs. OD600-normalized cell lysates were separated on 12% SDS-poly-
acrylamide gel electrophoresis (PAGE), followed by immunoblotting with anti-histidine poly-
clonal antibody (Santa Cruz Biotechnology, Inc.). The membrane was incubated with IRDye
conjugated anti-rabbit antibody to visualize the bands using Odyssey infrared imaging system
(LI-COR Biosciences).
In vivo glycosylation assay of Wzk activity
The ability of H. pyloriWzk to flip UndPP-linked glycans was tested in E. coli strain SCM6,
which contains mutations in the oligosaccharide translocase and O-antigen ligase [48]. We
should note that because the E. coli strains we used are K-12 strains, they do not produce O
antigen [49]. E. coli SCM6 carrying pACYCpglKmut (encoding the C. jejuni glycosylation
machinery with a mutation in the translocase gene pglK [50] and pIH18 (encoding histidine-
tagged AcrA as the acceptor protein) was transformed with either pIH23 (encoding Wzk) [32]
or its variant pIH23E525A (encoding WzkE525A). As a negative control, the empty vector
pEXT20 [51] was transformed instead of pIH23. To monitor Wzk in vivo activity, AcrA glyco-
sylation in different E. coli SCM6 strains was detected via immunoblotting. Cell lysates,
obtained from OD600-normalized overnight cultures, were separated on 12% SDS-PAGE. Fol-
lowing separation, proteins were transferred to a nitrocellulose membrane and were probed
using mouse anti-histidine monoclonal antibody and rabbit anti-C. jejuni glycan polyclonal
antibody. The membrane was incubated with IRDye conjugated anti-mouse and anti-rabbit
antibodies to visualize the bands using Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln, NE).
Construction of E. coli murJ complementation reporter strain
Previously, we developed a strain that reports on the ability of mutantmurJ alleles to comple-
ment a chromosomal ΔmurJ allele [22]. Here, we modified this system to test the ability of the
plasmids carrying the different H. pylori wzk alleles described above to complement the ΔmurJ
allele in E. coli. The bla gene that confers resistance to ampicillin in pRC7MurJ [22] was
replaced with a kan cassette that confers resistance to kanamycin using recombineering as fol-
lows. Primers BlaP1 and BlaP1 (S2 Table) were used to amplify the kan cassette from pKD4
[52]. The resulting PCR product was introduced into recombineering strain DY378 [43] carry-
ing pRC7MurJ and kanamycin-resistant recombinants were selected at 30°C on LB containing
kanamycin. Replacement of resistance markers was confirmed and the resulting plasmid
named pRC7KanMurJ.
ThemurJ complementation reporter strain was derived from the wild-type strain MG1655
[53] and constructed as follows. First, the ΔproC::kan allele from the Keio collection [54] was
introduced into MG1655 by P1 transduction. The resulting kanamycin-resistant NR2865 strain
was used in another P1 transduction using TB28 (proC+ ΔlacIYZA::FRT) as donor and select-
ing for growth on glucose M63 minimal plates lacking proline. Because proC and lacZ can be
co-transduced, lacZ transductants were identified as white colonies on glucose M63 minimal
plates containing IPTG and X-gal. The resulting MG1655 proC+ ΔlacIYZA::FRT strain was
named NR2869. The ΔpyrC::kan allele from the Keio collection [54] was then introduced into
NR2869 by selecting for kanamycin resistance. The kan gene was excised in the resulting trans-
ductant using the FLP-recombinase produced by pCP20 [55]. Then pRC7KanMurJ was intro-
duced into resulting strain to generate NR2874 [MG1655 ΔlacIZYA::FRT ΔpyrC::FRT
(pRC7KanMurJ)]. NR2874, a pyrimidine auxotroph that cannot grow in minimal medium
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because of the ΔpyrC::FRT allele, was then crossed via P1 transduction with pyrC+ ΔmurJ::kan
donor NR1648 [22] and pyrC+ transductants were selected on glucose M63 minimal plates con-
taining IPTG and X-gal. When the ΔmurJ::kan was acquired by co-transduction with pyrC+, the
desired MG1655 ΔlacIZYA::FRT ΔmurJ::kan (pRC7KanMurJ) transductants appeared as stably
blue colonies that could not lose pRC7KanMurJ. One such transductant was named NR2890.
We discarded transductants that formed white (or sectored blue/white) colonies because they
retained the wild-typemurJ allele and therefore lost pRC7KanMurJ.
Complementation of E. coli murJmutant with H. pylori wzk
Plasmids pEXT20, pIH23, and pIH23 derivatives encoding ATPase-deficient Wzk variants
WzkS405A, WzkD524A, andWzkE525A were introduced into strain NR2890 [MG1655 ΔlacI-
ZYA::FRT ΔmurJ::kan (pRC7KanMurJ)] and transformants were selected on LB solid medium
containing ampicillin and X-gal to yield merodiploid strains NR2919, NR2920, NR3649,
NR3648, and NR3650, respectively. Purified transformants were then plated onto LB solid
medium supplemented with ampicillin, X-gal, and various concentrations of IPTG to induce
expression of wzk alleles. Only NR2920 [MG1655 ΔlacIZYA::FRT ΔmurJ::kan (pRC7KanMurJ,
pIH23)] yielded a haploid strain, NR3647 [MG1655 ΔlacIZYA::FRT ΔmurJ::kan (pIH23)], in
the presence of 40 μM IPTG. For growth curves, strain NR3647 was grown overnight at 37°C
in LB broth supplemented with 40 μM IPTG in a culture roller drum (New Brunswick Scien-
tific). The culture was then diluted to OD600 0. 1 in LB either lacking or containing 40 μM
IPTG and growth was monitored by measuring OD600.
Microscopy
E. coli cells were spotted (2 μl of culture) on an LB agar pad and visualized on a Nikon Eclipse
Ti-E by phase contrast using a 100X oil objective lens.
Results and Discussion
ΔmurJ and Δwzk are synthetic lethal in H. pylori
MurJ is essential for the viability of several bacteria including E. coli, Burkholderia cenocepacia,
Burkholderia pseudomallei, Sinorhizobium meliloti, Staphylococcus aureus and Streptococcus
pneumoniae [16, 17, 24–27]. However, it is not essential in B. subtilis [29, 30] because this bac-
terium encodes an unrelated protein, AmJ, which can also flip lipid II [18]. Likewise, MurJ is
not essential inH. pylori but its loss leads to cell shape defects [41]. To identify the factor(s)
that might be redundant with MurJ inH. pylori, we first searched for AmJ homologs in the pro-
teome of this bacterium. A BLAST search [56] did not uncover any homologs of AmJ (NCBI
reference sequence NP_388304) encoded in the genomes ofH. pylori strains J99 (NCBI refer-
ence sequence NC_000921) and G27 (NCBI reference sequence NC_000915.1), suggesting that
a novel protein might be capable of flipping lipid II in this bacterium.
We hypothesized that Wzk might be the protein that is redundant with MurJ inH. pylori
because it is an ABC transporter that can flip various Und-PP-linked oligo- and poly- saccha-
rides across the cytoplasmic membrane [32]. Since lipid II translocation is required for viabil-
ity, we reasoned that if indeed MurJ and Wzk are redundant inH. pylori, nullmurJ and wzk
alleles will be synthetic lethal. Therefore, to test for such synthetic genetic interactions, we set
out to constructmurJ and wzk single and double mutants inH. pylori strain G27 where their
respective chromosomal alleles had been replaced with antibiotic-resistance cassettes, generat-
ing ΔmurJ::cat and Δwzk::aphA3 alleles.
Wzk Can Replace MurJ
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As previously reported, the singlemurJ and wzk single mutants (TSH1 and NSH203, respec-
tively) were viable [32, 41]. We noted that even though we easily generated the wzk::aphA3 sin-
gle NSH203 mutant, it grew slowly. We suspected that this growth defect might be caused by
the inhibition of the O-antigen biosynthetic pathway at the step where the Und-PP-linked O
antigen is translocated across the membrane. Inhibiting this step would likely cause a drop in
the pool of Und-P that is normally recycled after translocation of the Und-PP-linked O antigen
precursor and that is required for the synthesis of the essential lipid II (Fig 1). This situation
and phenotype would resemble those recently reported for E. coli strains in which pathways
that utilize Und-PP-linked oligosaccharide precursors have been inhibited at steps that prevent
recycling of Und-P [57, 58]. In E. coli, these defects were suppressed with mutations that pre-
vent the irreversible synthesis of the Und-PP-linked precursor by blocking the pathway
upstream. Therefore, we tested whether the growth defects we observed in theH. pylori wzk::
aphA3 single mutant NSH203 could be reversed by inactivating wecA, which encodes the
UDP-GlcNAc:Und-P GlcNAc-1-phosphate transferase that catalyzes the first step required for
the biosynthesis of the O antigen on its Und-P lipid carrier [32]. We found that in NSH208, a
ΔwecA allele suppressed the growth phenotypes conferred by wzk::aphA3. These results suggest
that like in E. coli, accumulation of dead-end Und-PP-linked intermediates causes growth
defects by depleting Und-P [57, 58].
Having confirmed that neithermurJ nor wzk are essential for the viability ofH. pylori, we
next attempted to construct a ΔmurJ::cat Δwzk::aphA3 double mutant by selecting for kanamy-
cin-resistant recombinants in the ΔmurJ::cat strain TSH1 following transformation with geno-
mic DNA obtained from the Δwzk::aphA3 strain NSH203. We failed to generate the ΔmurJ::cat
Δwzk::aphA3 double mutant. In contrast, we easily isolated kanamycin-resistant recombinants
when the recipient was strain TSH3, a ΔmurJ::cat that carries a wild-typemurJ allele at the
rdxA locus. These results indicate thatmurJ and wzk are a synthetic lethal pair.
While PG biogenesis is essential for the viability ofH. pylori, biosynthesis of the O antigen is
dispensable [32]. Furthermore, loss of Wzk disrupts O antigen biogenesis, indicating that MurJ
cannot substitute for Wzk in H. pylori [32]. Therefore, the synthetic lethality conferred by the
murJ and wzk alleles is likely the result of the loss of lipid II translocation. Consequently, we
propose that inH. pylori, both MurJ andWzk flip lipid II across the cytoplasmic membrane.
Wzk can substitute for MurJ in E. coli
The aforementioned results, combined with previous results showing that the O-antigen
flippase Wzk has relaxed substrate specificity [32], suggest that Wzk itself can flip lipid II in
H. pylori. Since MurJ is required for lipid II translocation in E. coli [20], we determined
whether heterologous expression of wzk in E. coli could complement a ΔmurJ chromosomal
allele.
We previously developed a method to easily determine whether a mutant allele ofmurJ
complements a ΔmurJ chromosomal allele and, if so, generate haploidmurJmutants in E. coli
[22]. We adapted this method to determine if H. pylori wzk can substitute for MurJ in E. coli as
follows. This ΔmurJ complementation system employs a strain (NR2890) that carries a ΔmurJ
chromosomal allele and a pRC7-derived mini-F plasmid [59] encoding a wild-typemurJ allele
and lacZ. This plasmid, pRC7KanMurJ, is also deficient in properly segregating upon cell divi-
sion [59]. As a result, ΔmurJ (pRC7KanMurJ) strains frequently generate ΔmurJ progeny that
has lost pRC7KanMurJ. Because MurJ is essential, the resulting ΔmurJ cells undergo MurJ
depletion and eventually lyse [16, 17]. Therefore, viable progeny of ΔmurJ (pRC7KanMurJ)
strain NR2890 must always carry pRC7KanMurJ and thereby be LacZ+. However, if a comple-
mentingmurJ allele is introduced into ΔmurJ (pRC7KanMurJ) cells, the resulting progeny will
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be a mixed population containing both merodiploid cells that still carry pRC7KanMurJ (Lac+)
and haploid cells that have lost pRC7KanMurJ (LacZ-). These haploid cells could be easily
identified as they will produce white colonies on plates containing the LacZ indicator X-gal
[22].
To determine whether H. pylori wzk can substitute for MurJ, we introduced plasmid
pEXT20 and its wzk-encoding derivative, pIH23 [32], into ΔmurJ (pRC7KanMurJ) cells. The
respective NR2919 and NR2920 transformants only yielded blue colonies in the presence of X-
gal. We then tested whether induction of wzk expression with IPTG could lead to complemen-
tation in NR2920. We observed that pIH23 could not complement the loss ofmurJ on plates
containing 20 μM IPTG. In addition, we observed that NR2920 grew poorly on plates
containing 0.2 mM IPTG likely because of the toxicity caused by overexpression of wzk.
However, when IPTG was present at 40 μM, the ΔmurJ (pRC7KanMurJ, pIH23) strain
NR2920 readily yielded white colonies, indicating that they lost pRC7KanMurJ. Further tests
demonstrated that the growth of these LacZ- cells (strain NR3647) was IPTG-dependent on
solid medium, indicating that their survival relies on wzk expression from pIH23. In contrast,
the ΔmurJ (pRC7KanMurJ, pEXT20) strain NR2919 only yielded blue colonies both in the
presence and absence of IPTG. Together, these results indicate that wzk can complement the
loss ofmurJ in E. coli (Fig 2A).
Although Wzk can substitute for MurJ in E. coli, complementation is not perfect. On LB
solid media containing 40 μM IPTG, the ΔmurJ (pIH23) strain NR3647 forms smaller colonies
than its ΔmurJ (pRC7KanMurJ) progenitor, strain NR2920, and the wild-type strain MG1655.
In liquid media, the ΔmurJ (pIH23) strain only reaches a cell density OD600 of ~0.4–0.6 when
shaken vigorously (data not shown) and of ~1.5 when grown in a cell culture roller drum (Fig
2B), while MurJ+ strains can typically reach OD600>3. Light microscopy also suggests that
ΔmurJ (pIH23) cells have PG defects because they exhibit shape defects and frequently undergo
lysis (Fig 2C). When strain NR3647 was subjected to Wzk depletion in liquid medium lacking
IPTG, we observed severe growth defects and an increase in lysis but depletion of Wzk was not
complete under conditions tested (S1 Fig).
Together, these results demonstrate that production of Wzk in E. coli is sufficient to sup-
press the lethality caused by the loss of MurJ but not to completely restore normal PG biogene-
sis. Similarly, H. pylorimutants lackingmurJ survive because they express wzk, albeit they
exhibit cell shape defects [41]. From these results we suggest that Wzk translocates lipid II
across the cytoplasmic membrane in bothH. pylori and E. coli because of its relaxed substrate
specificity of Und-PP-oligosaccharides. If so, the PG defects observed in MurJ- Wzk+ cells sug-
gest that Wzk cannot cope with the high demand for lipid II translocation in growing cells pos-
sibly because of inefficient recognition of lipid II.
ATPase activity is required for Wzk function and its ability to substitute
for MurJ in E. coli
We next tested if the ability of Wzk to substitute for MurJ is indeed dependent on its flippase
activity. To do this, we constructed a non-functional Wzk variant and tested its ability to com-
plement the loss ofmurJ in E. coli. The Und-PP-O-antigen flippase Wzk belongs to the ABC
transporter superfamily of proteins [32]. ABC transporters hydrolyze ATP and utilize the
energy released from ATP hydrolysis in the cytoplasm to undergo conformational changes that
result in the transport of substrates across membranes [60]. Since Wzk is predicted to rely on
ATP hydrolysis to function as a flippase, we constructed non-functional variants of Wzk by
changing residues that are highly conserved and essential for the ATPase activity of ABC
transporters.
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The ATPase components of ABC transporters contain highly conserved domains required
for the binding and hydrolysis of ATP. Specifically, these ATPases contain Walker A domains
with the consensus sequence GxxGxGK(T/S) and Walker B domains with the φφφφDE con-
sensus, where x and φ represent any amino acid and a hydrophobic amino acid, respectively
[60]. In Wzk (NCBI reference sequence WP_001074891), residues 398–405 (GHSGCGKS)
and 520-525(ILVLDE) correspond to the expected Walker A and Walker B domains. There-
fore, we expected that Wzk variants with changes in these motifs (S405A, D524A, or E525A)
would be non-functional. Using site-directed mutagenesis, we constructed the respective
mutant alleles of wzk in pIH23 and induced their expression in E. coli to analyze their stability.
We found that while WzkE525A was produced to similar levels as wild-type Wzk, the
WzkS405A andWzkD524A variants were produced at lower levels, suggesting that they have
decreased stability or defects in folding (Fig 3A). Therefore, we proceeded in our analysis using
the WzkE525A variant.
We tested the activity of WzkE525A in an in vivo flippase activity assay that takes advantage
of the fact that Wzk is a flippase with relaxed substrate specificity. In this assay, the E. coli strain
(SCM6) is used for the reconstitution of the Campylobacter jejuni proteinN-glycosylation
machinery [48]. AcrA, a well characterized C. jejuni glycoprotein, and the gene cluster responsi-
ble for itsN-glycosylation, were expressed in trans in E. coli SCM6 with the exception of C. jejuni
native flippase, PlgK, the ABC transporter that flips the lipid-linked N-oligosaccharide [31].
Because this strain lacks the endogenous flippases involved in O antigen and enterobacterial
common antigens, AcrA is not glycosylated unless an active translocase is present. To test the
flippase activity of WzkE525A, we introduced pIH23E525A and its control plasmids pEXT20
and pIH23 into strain SCM6, and monitored the glycosylation of AcrA in the three resulting
strains. As previously reported [32], we observed that AcrA was glycosylated in SMC6 strain har-
boring pIH23 but not the vector control, demonstrating that wild-typeWzk is required to substi-
tute for PglK (Fig 3B). Notably, we did not detect glycosylation of AcrA in strain SMC6 strain
harboring pIH23E525A (Fig 3B), indicating that the E525A substitution abolished the flippase
activity of Wzk, as would be expected from its inability to hydrolyze ATP.
Next, we tested for the ability of WzkE525A to substitute for MurJ in E. coli as described above.
Introducing pIH23E525A into the ΔmurJ (pRC7KanMurJ) reporter strain did not complement
the ΔmurJmutation as indicated by the detection of only blue colonies of strain NR3649 in our
MurJ complementation assay. Moreover, addition of various amounts of IPTG never promoted
the generation of white (i.e. ΔmurJ) colonies, indicating that WzkE525A cannot substitute for
MurJ in E. coli (Fig 2A). We also tested theWzkS405A andWzkD524A variants in the event that
they retained activity despite their folding defects but they did not complement the loss of MurJ in
strain NR3649 and NR3648, respectively. Together, all of these results indicate that the ATPase
activity of Wzk is required for its ability to function as a flippase of the Und-PP-linked precursor
used inN-glycosylation, and to substitute for MurJ in E. coli. These findings support a model
whereWzk complements the loss of MurJ by flipping lipid II in an ATP-dependent manner.
Fig 2. Wzk can substitute for MurJ in E. coli. (A) Summary of complementation experiments. The loss of
murJ in E. coli can only be accomplished with a plasmid encoding wild-typewzk. ThewzkE525A allele, which
carries a mutation in theWalker B motif that is required for ATPase activity, cannot complement a ΔmurJ
allele. (B) Growth of E. coli strain NR3647 [MG1655 ΔlacIZYA::FRT ΔmurJ::kan (pIH23)] in LB broth
supplemented with 40 μM IPTG as determined by OD600. The data represents the average and standard
deviation of six independent cultures. (C) E. coli strain NR2920 (MG1655 ΔlacIYZA::FRT ΔmurJ::kan
(pRC7KanMurJ, pIH23) expressing bothmurJ andwzk exhibits the rod-shape cellular morphology typical of
wild-type E. coli cells (MurJ+ Wzk+ panel) under a 100X phase-contrast objective. ΔmurJ cells complemented
withwzk (Wzk+ panels) exhibit morphology characteristic of cells with PG defects: larger size, aberrant
morphology, and lysis (marked with white arrow heads).
doi:10.1371/journal.pone.0161587.g002
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Fig 3. Generation of enzymatically inactiveWzk variant. (A) Expression of differentH. pyloriWzk variants
was induced by IPTG in E. coli DH5α for 4 h. Cell lysates from normalized cultures were separated on
SDS-PAGE, followed by immunoblotting to detect the expression levels of Wzk mutants relative to wild type
enzyme. Among the different Wzk variants, WzkE525A displayed expression levels comparable to that of
wild type. (B) WzkE525A flippase activity is diminished in vivo. Both AcrA from C. jejuni and the accessory
gene cluster required for its N-glycosylation were reconstituted in E. coli, with the exception of the native
flippase. Flippase activity of Wzk and its E525A variant was tested by monitoring the glycosylation levels of C.
jejuni AcrA via immunoblotting. Monoclonal anti-histidine was used to detect the expression of histidine-
tagged AcrA (green), while theC. jejuni glycan was detected by the rabbit polyclonal anti-C. jejuni glycan
(red). The glycosylated form of AcrA (G) is marked by the colocalization of both signals (yellow).
Unglycosylated form of AcrA is marked U.
doi:10.1371/journal.pone.0161587.g003
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Conclusions
Translocation of lipid II across the cytoplasmic membrane is an essential step in PG biogenesis
[12]. The controversy surrounding the identification of lipid II flippases has hampered progress
in understanding the mechanism of lipid II translocation [15]. Specifically, the debate sur-
rounding MurJ was fueled by the fact that even though MurJ is essential for PG biogenesis in E.
coli and other species, it is not in B. subtilis andH. pylori [29, 30, 41]. Here, we have demon-
strated that like B. subtilis, H. pylori has another protein that is functionally redundant with
MurJ [18]. In H. pylori, this protein is Wzk, a promiscuous Und-PP-oligosaccharide flippase
[32]. Although MurJ flippase activity has not been reconstituted in vitro, the fact that Wzk is
an ABC transporter that is functionally redundant with MurJ, together with previous findings
on MurJ structure and function, strongly support that MurJ itself flips lipid II [20, 22, 23].
In addition, it is important to note AmJ and Wzk, which are functionally redundant with
MurJ, show no evolutionary relationship with each other or MurJ [18]. These results have sev-
eral implications. First, they demonstrate that cell viability should not be used as the only
marker for the identification of flippases in gene clusters encoding essential glycans like PG.
This type of argument has been used not only against MurJ [29, 30] but also against Rft1, a
member of the MOP exporter superfamily that has been proposed and refuted to be a flippase
required for N-glycosylation in eukaryotes [21, 61, 62]. Second, they highlight the need for
studies that focus on understanding substrate specificity and mechanism of function of flip-
pases of polyisoprenoid-linked oligosaccharides. Third, PG biogenesis has been the target of
antibiotics that have been effective in the clinic [4]. In principle, MurJ has the potential to be
the target of novel antibiotics and, indeed, it has been shown that small molecules that rapidly
inactivate engineered MurJ variants cause cell lysis in E. coli [20]. However, the fact that some
bacterial species encode factors that are functionally redundant with MurJ suggests that small
molecule inhibitors of MurJ might have a narrower spectrum than anticipated. Therefore, this
study highlights the importance of broadening the screening strategies for MurJ inhibitors to
target other functionally-redundant proteins as well. Furthermore we suggest that Wzk is more
promiscuous than other flippases such as Wzx. Wzx flippases are known to only flip lipid-
linked oligosaccharides and the first sugar is important for recognition or activity [63–67].
However, Wzk appears to be able to flip long Lewis antigen chains in Helicobacter pylori and
also shorter oligosaccharides, such as O antigens subunits or the N-heptasaccharide from C.
jejuni [32], and, as we suggest here, lipid II, which is composed of sugars and amino acids.
Recently, the three dimensional structure of PglK, the C. jejuni ortholog of Wzk, has been
reported [40]. A flipping mechanism has been proposed in which the pyrophosphate moiety
and the oligosaccharide are shielded from the lipid bilayer in a translocation cavity. Further
work is required to understand howWzk is able to shield both long polysaccharide chains and
short oligosaccharide units.
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S1 Fig. Growth of E. coli strain NR3647 is dependent on expression of wzk. Growth of E.
coli strain NR3647 [MG1655 ΔlacIZYA::FRT ΔmurJ::kan (pIH23)] in LB broth supplemented
with 40 μM IPTG (black-filled circles) or not (white-filled circles) as determined by OD600.
The overall curve is representative of at least three independent experiments. A culture of
NR3647 grown overnight in LB containing IPTG was diluted to OD600 0.1 in LB either contain-
ing or not IPTG. Growth of NR3647 was dependent on the presence of IPTG. As Wzk was
depleted in the absence of IPTG, OD600 stopped increasing. Complete lysis of the culture was
not observed likely because of leaky expression of wzk.
(PDF)
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